Pulmonary Medicine
CD117 immunoreactivity identifies patients with highly aggressive lung cancers
Published in Cancer Weekly, October 12th, 2004
According to published research from Italy, "CD117, a trans-membrane tyrosine kinase receptor, has been immunolocalized in a large variety of human neoplasms. Little, however, is known about the prevalence and clinical implications of CD117 in stage I adenocarcinoma and squamous cell carcinoma of the lung."
"We evaluated 201 consecutive stage I adenocarcinoma and squamous cell carcinoma of the lung for CD117 immunoreactivity (dichotomized as negative or positive if containing <5% or {{>=}}5% immunoreactive neoplastic cells, respectively), also taking into account...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-10-12)
More Articles from Cancer Weekly
- Cancer Epidemiology
VDR polymorphisms may heighten prostate cancer risk in African Americans - Endometrial Cancer
Letrozole has limited activity in advanced endometrial cancer - Human Papillomavirus
High-risk HPV oncogene transcripts detected in cervical scrapes - Liver Cancer
Comparative genomic hybridization tracks the genetics of HCV-related cancer - Adenocarcinomas
hCG lacks specificity for malignant cells to be of clinical use in effusion cytology - Antibody Development
Collaboration to develop fully human antibody therapeutics for cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
